[Congressional Record Volume 168, Number 100 (Monday, June 13, 2022)]
[House]
[Pages H5451-H5452]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]




                    CONTINUATION OF THE 340B PROGRAM

  (Mr. BERGMAN asked and was given permission to address the House for 
1 minute and to revise and extend his remarks.)
  Mr. BERGMAN. Madam Speaker, I rise today to highlight the positive 
accomplishments and ongoing challenges facing healthcare providers in 
rural and remote parts of our country, especially in places like 
Michigan's First District, my home.
  Last week marked the 30th anniversary of the 340B Federal drug 
pricing program, which provides discounted pharmaceutical products to 
providers that care for a disproportionate share of uninsured and at-
risk patients.
  In my district alone, we have 20 340B hospitals providing care for 
our most vulnerable patient populations and ensuring our rural and 
remote communities receive the best possible care available.
  This program has been a critical component of healthcare for so many

[[Page H5452]]

Michiganders, and I hope to work with my colleagues to ensure its 
continued success, especially as it faces new challenges that could 
threaten its efficacy in the future.
  As the COVID-19 pandemic has shown us, reliable access to care, along 
with the availability of prescription drugs and specialist medical 
treatments, is more important than ever.
  Our rural and remote providers will continue to do everything in 
their power to provide top-of-the-line care to our patients. In turn, 
Congress must continue to address those rural health priorities.

                          ____________________